BioCentury
ARTICLE | Clinical News

Repatha evolocumab regulatory update

May 11, 2015 7:00 AM UTC

FDA’s Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) will meet on June 10 to discuss a BLA from Amgen for Repatha evolocumab to treat high cholesterol. The PDUFA date is Aug. 27. Amgen ...